Warburg effect modulated by deubiquitinating enzymes and their substrates (Homo sapiens)

Jump to: navigation, search

Cancer cells use aerobic glycolysis as their main source for energy production, even in the presence of oxygen. This process is called the Warburg effect. This pathway shows the effects deubiquitinating enzymes (DUBs) and their substrates have. DUBs free proteins of their ubiquitin chain, so that the proteins can resume their function in the cells rather than be degraded by the ubiquitin-proteasome system (UPS).

The deubiquitination of VHL via OTUD6B (part of a DUB subfamily) represses HIF-1α, whereas the direct deubiquitination of HIF-1a via DUBs leads to the increased expression of GLUT1 and VEGF. The transcription factor c-Myc helps regulate gene expression involved in the glucose metabolism (e.g., GLUT1, HK2, LDHA) and is stabilised by ubiquitin-specific proteases. The PI3K/Akt pathway is also upregulated by deubiquitination of VEGF and Akt. This entails cell growth and apoptosis regulation, as well as promoted glucose transport to cancer cells and activating mTor, which improves glycolysis. It is shown in this pathway, how deubiquitinating enzymes play an important role in stabilizing different proteins, acting as oncoproteins and tumor suppressors equally.

This pathway is based on figure 3 featured in “Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect” by So-Hee Kim and Kwang-Hyun Baek.